Abstract:Abstract Background and Aims IgA nephropathy is the most common primary glomerulonephritis worldwide. There is growing evidence of host immunity is closely related to the pathogenesis of IgAN, but the detailed mechanism in the early stages of IgAN remain largely unknown. In this study, we applied single-cell RNA-seq technology to investigate the transcriptomic changes in PBMCs and kidney tissues of early stage IgAN patients at the single-cell resolution. This study aims to establish a immune and kidney cell landscape of IgAN, and offers new insights for the diagnosis and treatment of IgAN. Method In strict accordance to the admission criteria, collect peripheral venous blood and kidney samples of healthy donors and newly diagnosed IgAN patients, prepare single cell solution, verify cell viability by flow cytometry, and perform single-cell RNA-seq using a BD Rhapsody platform. Meanwhile, the clinical data of healthy donors and IgAN patients were collected and analysed. Finally, the correlation and association of differential expressed genes (DEGs) and cell clusters-identified by single-cell RNA-seq with the clinical data of IgAN were investigated. Results First, we established immune cells and kidney cells landscape of IgAN. The differentially expressed genes (DEGs) between the control group and IgAN were mainly concentrated in the NK cell-mediated cytotoxicity and cell killing pathways. Interestingly, we found significant decreases in NK cell numbers and cytotoxicity, and NK cell numbers and marker genes were negatively correlated with clinical parameters, including urinary protein creatinine ratio (UPCR) and serum galactose-deficient IgA1 and IgA. In contrast, B cell DEGs were enriched in different viral infection pathways, and one specific B cell subgroup showed inhibition of NFκB signaling, which was positively correlated with clinical parameters. In addition, a subpopulation of monocytes expressing interferon-inducing genes was positively associated with clinical severity of IgAN. In case of the kidney tissue, compared with the control group, mesangial cells of IgAN patients up-regulated extracellular matrix, transcription factors, kidney development and genes related to the regulation of Wnt signaling pathway. The expression of structural protein ITGA8 on mesangial cells was significantly decreased, indicating the mesangial cells were damaged in early IgAN. Pseudo-time analysis indicated that extracellular matrix-related genes were involved in mesangial cell lesion. We also found that the patie'ts' glomerular endothelial cells expressed high level of angiogenesis and VEGF- related genes. Moreover, podocytes of IgAN patients expressed genes of cytoskeletal recombination and FGFR activation. Conclusion We successfully established the single-cell landscapes of peripheral blood immune cells and kidney cells in early IgAN patients, which revealed changes in the number and status of immune cells and kidney cells closely related to clinical manifestations and phenotypic transformation. Our study offers new insights for the diagnosis and treatment of IgAN.

Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy

Analysis of m6A regulators related immune characteristics in ankylosing spondylitis by integrated bioinformatics and computational strategies

Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis

m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy

Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity.

m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma

Characterization of m6A regulator‐mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia

Comprehensive Analysis of Aberrantly Expressed Profiles of Mrna and Its Relationship with Serum Galactose-Deficient IgA1 Level in IgA Nephropathy

Integrated analysis of m6A regulator-mediated RNA methylation modification patterns and immune characteristics in Sjögren’s Syndrome

Identification of key genes with abnormal RNA methylation modification and selected m6A regulators in ankylosing spondylitis

Integrated analysis of m6A regulator-mediated RNA methylation modification patterns and immune characteristics in Sjögren's syndrome

Differentially expressed long non‑coding RNAs and mRNAs in patients with IgA nephropathy

Genome-wide analysis of long noncoding RNAs as cis -acting regulators of transcription factor-encoding genes in IgA nephropathy

Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database

Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer

#3764 SINGLE-CELL RNA-SEQ REVEALS IMMUNE AND KIDNEY CELL TYPE–SPECIFIC MOLECULAR ASSOCIATIONS TO IGA NEPHROPATHY

Single-cell RNA-sequencing Reveals Distinct Immune Cell Subsets and Signaling Pathways in IgA Nephropathy

Immune Infiltration of Ulcerative Colitis and Detection of the M6a Subtype

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma

Association Analysis of DNA Methyltransferases in IgA Nephropathy

m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of coronary heart disease